Crossmark

Involuted TLS as a harbinger of HCC regression

Crossref DOI link: https://doi.org/10.1038/s41590-024-01990-y

Published Online: 2024-10-25

Published Print: 2024-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Liu, Xin https://orcid.org/0000-0002-7529-3149
Duda, Dan G. https://orcid.org/0000-0001-7065-8797
License Information

Text and Data Mining valid from 2024-10-25

Version of Record valid from 2024-10-25
More Information

Article History

First Online: 25 October 2024

Competing interests

: D.G.D. declares research grants from Bayer, Exelixis, Surface Oncology, and Bristol Myers Squibb. X.L. declares no competing interests.